| Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence P Kahl, L Gullotti, LC Heukamp, S Wolf, N Friedrichs, R Vorreuther, ... Cancer research 66 (23), 11341-11347, 2006 | 562 | 2006 |
| Circulating microRNAs (miRNA) in serum of patients with prostate cancer R Mahn, LC Heukamp, S Rogenhofer, A von Ruecker, SC Müller, ... Urology 77 (5), 1265. e9-1265. e16, 2011 | 300 | 2011 |
| MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels LM Wulfken, R Moritz, C Ohlmann, S Holdenrieder, V Jung, F Becker, ... PloS one 6 (9), e25787, 2011 | 286 | 2011 |
| Global levels of histone modifications predict prostate cancer recurrence J Ellinger, P Kahl, J Von Der Gathen, S Rogenhofer, LC Heukamp, ... The Prostate 70 (1), 61-69, 2010 | 253 | 2010 |
| Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer I Syring, J Bartels, S Holdenrieder, G Kristiansen, SC Müller, J Ellinger The Journal of urology 193 (1), 331-337, 2015 | 209 | 2015 |
| Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci PJ Bastian, J Ellinger, A Wellmann, N Wernert, LC Heukamp, SC Müller, ... Clinical Cancer Research 11 (11), 4097-4106, 2005 | 178 | 2005 |
| Soy isoflavone genistein in prevention and treatment of prostate cancer FGE Perabo, EC Von Löw, J Ellinger, A Von Rücker, SC Müller, ... Prostate Cancer and Prostatic Diseases 11 (1), 6-12, 2008 | 177 | 2008 |
| CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer J Ellinger, PJ Bastian, T Jurgan, K Biermann, P Kahl, LC Heukamp, ... Urology 71 (1), 161-167, 2008 | 175 | 2008 |
| Primitive neuroectodermal tumor: rare, highly aggressive differential diagnosis in urologic malignancies J Ellinger, PJ Bastian, S Hauser, K Biermann, SC Müller Urology 68 (2), 257-262, 2006 | 166 | 2006 |
| CpG island hypermethylation in cell‐free serum DNA identifies patients with localized prostate cancer J Ellinger, K Haan, LC Heukamp, P Kahl, R Büttner, SC Müller, ... The Prostate 68 (1), 42-49, 2008 | 161 | 2008 |
| Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer J Ellinger, V Wittkamp, P Albers, FGE Perabo, SC Mueller, A von Ruecker, ... The Journal of urology 181 (1), 363-371, 2009 | 147 | 2009 |
| Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node–negative urothelial carcinoma of … M May, E Herrmann, C Bolenz, S Brookman-May, A Tiemann, R Moritz, ... Annals of surgical oncology 18, 2018-2025, 2011 | 139 | 2011 |
| Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? AR Scheffer, S Holdenrieder, G Kristiansen, A von Ruecker, SC Müller, ... World journal of urology 32, 353-358, 2014 | 135 | 2014 |
| Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma J Ellinger, P Kahl, C Mertens, S Rogenhofer, S Hauser, W Hartmann, ... International journal of cancer 127 (10), 2360-2366, 2010 | 132 | 2010 |
| Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators J Ellinger, PJ Bastian, KI Haan, LC Heukamp, R Buettner, R Fimmers, ... International journal of cancer 122 (1), 138-143, 2008 | 131 | 2008 |
| Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies J Ellinger, DC Müller, SC Müller, S Hauser, LC Heukamp, A von Ruecker, ... Urologic oncology: seminars and original investigations 30 (4), 509-515, 2012 | 123 | 2012 |
| Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker J Ellinger, P Albers, SC Müller, A Von Ruecker, PJ Bastian BJU international 104 (1), 48-52, 2009 | 123 | 2009 |
| Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma S Hauser, LM Wulfken, S Holdenrieder, R Moritz, CH Ohlmann, V Jung, ... Cancer epidemiology 36 (4), 391-394, 2012 | 122 | 2012 |
| Global histone acetylation levels: prognostic relevance in patients with renal cell carcinoma D Mosashvilli, P Kahl, C Mertens, S Holzapfel, S Rogenhofer, S Hauser, ... Cancer science 101 (12), 2664-2669, 2010 | 116 | 2010 |
| H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 … C Magerl, J Ellinger, T Braunschweig, E Kremmer, LK Koch, T Höller, ... Human pathology 41 (2), 181-189, 2010 | 115 | 2010 |
